Prostaglandin E2, but not cAMP nor β2-agonists, induce tristetraprolin (TTP) in human airway smooth muscle cells
- 9 March 2019
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 68 (5) , 369-377
Abstract
Tristetraprolin (TTP) is an anti-inflammatory molecule known to post-transcriptionally regulate cytokine production and is, therefore, an attractive drug target for chronic respiratory diseases driven by inflammation, such as asthma and chronic obstructive pulmonary disease. Our recent in vitro studies in primary human airway smooth (ASM) cells have confirmed the essential anti-inflammatory role played by TTP as a critical partner in a cytokine regulatory network. However, several unanswered questions remain. While prior in vitro studies have suggested that TTP is regulated in a cAMP-mediated manner, raising the possibility that this may be one of the ways in which β2-agonists achieve beneficial effects beyond bronchodilation, the impact of β2-agonists on ASM cells is unknown. Furthermore, the effect of prostaglandin E2 (PGE2) on TTP expression in ASM cells has not been reported. We address this herein and reveal, for the first time, that TTP is not regulated by cAMP-activating agents nor following treatment with long-acting β2-agonists. However, PGE2 does induce TTP mRNA expression and protein upregulation in ASM cells. Although the underlying mechanism of action remains undefined, we can confirm that PGE2-induced TTP upregulation is not mediated via cAMP, or EP2/EP4 receptor activation, and occurred in a manner independent of the p38 MAPK-mediated pathway. Taken together, these data confirm that β2-agonists do not upregulate TTP in human ASM cells and indicate that another way in which PGE2 may achieve beneficial effects in asthma and COPD may be via upregulation of the master controller of inflammation—TTP.Keywords
Funding Information
- National Health and Medical Research Council
This publication has 25 references indexed in Scilit:
- Long-Acting β2-Agonists Increase Fluticasone Propionate-Induced Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1) in Airway Smooth Muscle CellsPLOS ONE, 2013
- RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathwaysFrontiers in Immunology, 2012
- The mRNA‐Binding Protein Zfp36 Is Upregulated by β‐Adrenergic Stimulation and Represses IL‐6 Production in 3T3‐L1 AdipocytesObesity, 2012
- Compounds That Increase or Mimic Cyclic Adenosine Monophosphate Enhance Tristetraprolin Degradation in Lipopolysaccharide-Treated Murine J774 MacrophagesThe Journal of Pharmacology and Experimental Therapeutics, 2008
- A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroidsBritish Journal of Pharmacology, 2008
- Salbutamol increases tristetraprolin expression in macrophagesLife Sciences, 2007
- Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2Molecular Pharmacology, 2005
- Tumor Necrosis Factor-α –Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells: Modulation by Cyclic Adenosine MonophosphateAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- The Maintenance of Functional Activity in Human Isolated Bronchus after CryopreservationPulmonary Pharmacology, 1995
- Sequence of a rat TIS11 cDNA, an immediate early gene induced by growth factors and phorbol estersGene, 1992